Suppr超能文献

遗传性非球形细胞溶血性贫血所致铁过载导致的肝硬化

Liver cirrhosis as a consequence of iron overload caused by hereditary nonspherocytic hemolytic anemia.

作者信息

Hilgard Philip, Gerken Guido

机构信息

Universitatsklinikum Essen, Klinik fur Gastroenterologie and Hepatologie, Hufelandstrabe 55, 45122 Essen, Germany.

出版信息

World J Gastroenterol. 2005 Feb 28;11(8):1241-4. doi: 10.3748/wjg.v11.i8.1241.

Abstract

Nonspherocytic hereditary anemias are occasionally accompanied by significant iron overload but the significance for the development of chronic liver disease is not clear. We described two cases of patients with chronic liver disease and severe iron overload due to chronic hereditary hemolysis. Both patients have had signs of liver cirrhosis and severe hemolysis since childhood. A hereditary pyruvate kinase deficiency (PKD) was discovered as the underlying reason for the hemolysis. Sequencing of the pyruvate kinase gene showed a mutation within exon 11. Liver histology in both patients revealed cirrhosis and a severe iron overload but primary hemochromatosis was excluded by HFE-gene analysis. An iron reduction therapy with desferrioxamine led to significant decrease of serum ferritin and sustained clinical improvement. PKD-induced hemolysis may cause severe iron overload even in the absence of HFE-genotype abnormalities. This secondary iron overload can lead to chronic liver disease and cirrhosis. Therefore, the iron metabolism of PKD patients has to be closely monitored and iron overload should be consequently treated.

摘要

非球形细胞性遗传性贫血偶尔会伴有显著的铁过载,但对慢性肝病发展的意义尚不清楚。我们描述了两例因慢性遗传性溶血导致慢性肝病和严重铁过载的患者。两名患者自童年起就有肝硬化和严重溶血的迹象。发现遗传性丙酮酸激酶缺乏症(PKD)是溶血的根本原因。丙酮酸激酶基因测序显示第11外显子内有一个突变。两名患者的肝脏组织学检查均显示肝硬化和严重铁过载,但通过HFE基因分析排除了原发性血色素沉着症。去铁胺铁还原疗法导致血清铁蛋白显著降低,并持续改善临床症状。即使在没有HFE基因型异常的情况下,PKD诱导的溶血也可能导致严重的铁过载。这种继发性铁过载可导致慢性肝病和肝硬化。因此,必须密切监测PKD患者的铁代谢,并相应地治疗铁过载。

相似文献

1
Liver cirrhosis as a consequence of iron overload caused by hereditary nonspherocytic hemolytic anemia.
World J Gastroenterol. 2005 Feb 28;11(8):1241-4. doi: 10.3748/wjg.v11.i8.1241.
2
Successful Liver Transplantation for Adolescent Patient With Pyruvate Kinase Deficiency-induced Cirrhosis.
J Pediatr Hematol Oncol. 2021 May 1;43(4):e605-e607. doi: 10.1097/MPH.0000000000001876.
3
How we manage patients with pyruvate kinase deficiency.
Br J Haematol. 2019 Mar;184(5):721-734. doi: 10.1111/bjh.15758. Epub 2019 Jan 25.
4
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency.
Blood Adv. 2024 May 28;8(10):2433-2441. doi: 10.1182/bloodadvances.2023011743.
6
Successful Liver Transplants for Liver Failure Associated With Pyruvate Kinase Deficiency.
Pediatrics. 2018 Apr;141(Suppl 5):S385-S389. doi: 10.1542/peds.2016-3896.
7
Management of pyruvate kinase deficiency in children and adults.
Blood. 2020 Sep 10;136(11):1241-1249. doi: 10.1182/blood.2019000945.
8
Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases.
Blood Cells Mol Dis. 2001 May-Jun;27(3):653-61. doi: 10.1006/bcmd.2001.0433.
9
An evaluation of mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency.
Expert Rev Hematol. 2022 Oct;15(10):875-885. doi: 10.1080/17474086.2022.2125865. Epub 2022 Sep 22.
10
Identification and in silico characterization of a novel PKLR genotype in a Turkish newborn.
Mol Biol Rep. 2020 Oct;47(10):8311-8315. doi: 10.1007/s11033-020-05836-2. Epub 2020 Sep 24.

引用本文的文献

1
Acute-on-Chronic Liver Failure and Successful Liver Transplantation in Pyruvate Kinase Deficiency.
ACG Case Rep J. 2023 Sep 5;10(9):e01143. doi: 10.14309/crj.0000000000001143. eCollection 2023 Sep.
3
Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency.
Mol Ther. 2016 Aug;24(7):1187-98. doi: 10.1038/mt.2016.87. Epub 2016 May 3.
4
Prominent basophilic stippling and hemochromatosis in glucose-6-phosphate dehydrogenase deficiency.
Int J Hematol. 2015 Feb;101(2):112-3. doi: 10.1007/s12185-014-1716-6. Epub 2014 Dec 9.
5
Bilirubin cholelithiasis and haemosiderosis in an anaemic pyruvate kinase-deficient Somali cat.
J Small Anim Pract. 2008 Sep;49(9):479-82. doi: 10.1111/j.1748-5827.2008.00568.x. Epub 2008 Aug 5.
6
Clinical course of pyruvate kinase deficiency in Abyssinian and Somali cats.
J Feline Med Surg. 2008 Apr;10(2):145-53. doi: 10.1016/j.jfms.2007.09.006. Epub 2008 Feb 20.

本文引用的文献

3
Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases.
Blood Cells Mol Dis. 2001 May-Jun;27(3):653-61. doi: 10.1006/bcmd.2001.0433.
4
Pathogenesis of liver fibrosis: role of oxidative stress.
Mol Aspects Med. 2000 Jun;21(3):49-98. doi: 10.1016/s0098-2997(00)00004-2.
7
Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: tabulation of mutant enzymes.
Am J Hematol. 1996 Feb;51(2):122-32. doi: 10.1002/(SICI)1096-8652(199602)51:2<122::AID-AJH5>3.0.CO;2-#.
9
Hemolytic anemias.
Rev Invest Clin. 1994 Apr;Suppl:162-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验